Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Nutraceutical Contract Manufacturing Services Market Outlook (2023 to 2033)

The global nutraceutical contract manufacturing services market is poised to attain remarkable growth from 2023 to 2033. According to the research report published by FMI, the global market is anticipated to surpass a valuation of US$ 149.41 billion in 2023. It is likely to reach a valuation of US$ 466.11 billion by 2033. The market is projected to exhibit an astonishing CAGR of 12.05% from 2023 to 2033. The increasing demand for personalized nutrition is expected to foster market development. Additionally, the growing heath consciousness is predicted to aid market expansion.

The demand for nutraceutical products is consistently rising. The awareness concerning the benefits of nutraceuticals consumption has significantly grown in recent years. The increasing urbanization and the rising expenditure on health-related products is expected to aid market development. Furthermore, the increasing prevalence of obesity, cardiovascular, and other chronic diseases is giving a push nutraceutical industry. The growing demand for functional foods and nutraceutical supplements is expected to drive market growth.

Technological advancements in the healthcare industry are rising. The availability of advanced technologies is creating ample growth opportunities for market players. The nutraceutical industry is anticipated to gain more benefits from contract manufacturing services during the forecast period. Factors such as improved shipping options, extensive lab testing, and decreased overhead costs are expected to benefit the industry. Additionally, the economic production and better reliability factors are anticipated to aid market development.

The increasing demand nutraceuticals has led manufacturers to develop and launch newer types of products. Manufacturers are launching products in a myriad of sizes, shapes, and flavors. Soft gels, jellies, and gummies are a few kinds of nutraceutical products gaining popularity. They are also liked by kids, which creates opportunities for manufacturers to engage in products for young kids. Additionally, gummies and jellies are also preferred by the geriatric population, which is a huge target population.

The increasing chronic diseases among female population is driving the development of new nutraceuticals. Manufacturers are developing functional nutraceutical foods and beverages to address women in specific life stages. The evolving landscape of nutraceuticals for women is predicted to create new growth avenues. For instance, WellSource Nutraceuticals launched a nutritional supplement in May 2020. The new supplement was developed for women in fertility programs.

Attributes Details
Nutraceutical Contract Manufacturing Services Market Share (2022) US$ 133.34 billion
Nutraceutical Contract Manufacturing Services Market (2023) US$ 149.41 billion
Nutraceutical Contract Manufacturing Services Market (2033) US$ 466.11 billion
Nutraceutical Contract Manufacturing Services Market (2023 to 2033) 12.05%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Global Nutraceutical Contract Manufacturing Services Market Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)

According to the report published on nutraceutical contract manufacturing services market, the deployment of these services is rising every year. In 2018, the global market size stood at nearly US$ 84.59 billion. In the following years from 2018 to 2022, the market showcased remarkable growth, accounting for a worth of US$ 133.34 billion.

The increasing chronic diseases and expanding geriatric population are expected to the key factors driving market growth. The growing demand for nutraceuticals by the geriatric population is accelerating market expansion. Furthermore, the demand for customized medicine is rising. Due to the increasing prevalence of chronic diseases, experts are formulating medicine that give the best results on consumption. The growing awareness for herbal and organic nutraceuticals is expected to increase nutraceutical contract manufacturing services adoption.

The adoption of innovative production strategies is anticipated to create growth avenues for market players. Additionally, the expansion of production capabilities is predicted to uptick market expansion. For instance, Star Combo Pharma announced its facility expansion in June 2022. The renowned distributer and manufacturer of nutritional, beauty, and health products inaugurated their new manufacturing facility in New South Wales, Australia.

Category-wise Insights

Which Product Type is Anticipated to Hold the Most Prominent Share in the Global Nutraceutical Contract Manufacturing Services Market?

Functional Foods and Beverages Segment to Register a Noteworthy CAGR

According to the segmentation based on product type, the market is bifurcated into functional foods & beverages, and dietary supplements. The functional food and beverages segment is predicted to register a remarkable CAGR of 12.2% from 2023 to 2033. Functional foods and beverages serve several health advantages. The growing awareness for these advantages is anticipated to fuel their consumption in coming years. The rising demand is anticipated to increase contract manufacturing services in nutraceutical industry.

The coronavirus pandemic gave a significant push to the consumption of functional beverages and foods. Nations such as India, Japan, China, and South Korea have witnessed an increased consumption of functional foods post-pandemic.

Which Dosage Form is Predicted to Garner Prominent Revenues?

Tablets Segment to Retain Dominance in Global Market

According to the segmentation based on dosage type, the market is classified into powder in sachet/jar, energy bars, gummies, liquid oral, capsules, and tablets. Among these, the tablets segment is anticipated to garner prominent revenues in the global market. The dominance of this segment can be attributed to several factors. Tablets are easy to manufacture and have a long shelf life. They can be customized using different sizes, shapes, and coatings according to requirement. Hence, launches of nutraceutical tablets is anticipated to aid market development. In November 2021, Nature’s Sunshine Products collaborated with Nutraceutical Sciences Institute to launch a new line of immunity-supporting supplements. The new range comprises elderberry pills and candies.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of Adjacent Nutraceutical Contract Manufacturing Services Market

Nutraceutical Contract Manufacturing Services Market:

Attributes Nutraceutical Contract Manufacturing Services Market
CAGR (2023 to 2033) 12.05%
Market Value (2023) US$ 149.41 billion
Growth Factor Increasing chronic diseases and expanding geriatric population.
Future Opportunities Innovations in production technologies and product developments.
Market Trends Increasing awareness for maintaining optimum health.

Nutraceuticals Market:

Attributes Nutraceuticals Market
CAGR (2023 to 2033) 8.3%
Market Value (2023) US$ 435.91 billion
Growth Factor Rising consumption of high nutritional supplements.
Future Opportunities Partnerships and collaborations among market players to increase brand awareness.
Market Trends Rising concern for maintaining healthy lifestyle.

Nutraceutical Gummies Market:

Attributes Nutraceutical Gummies Market
CAGR (2023 to 2033) 13.4%
Market Value (2023) US$ 29.1 billion
Growth Factor Increasing trends of eating organic and vegan food products.
Future Opportunities Entrance of new market players in markets in regions such as India and Japan.
Market Trends Easy accessibility and availability to boost product demand.

Country-wise Insights

Why is Asia Pacific the Frontrunner in the Global Market?

Asia Pacific generated revenues greater than any region in 2022. The region accounted for more than 40% global market share in 2022. The robust demand from nations such as Australia, South Korea, India, and Japan is attributable to this growth. The improving healthcare infrastructure in these nations is resulting in increased demand for nutraceuticals. The numbers of nutraceutical contract manufacturing service providers are rising in these, fostering market development. The growing consciousness for healthy lifestyles and improving income levels support market development.

The presence of renowned manufacturers in Asia Pacific is likely to contribute to market growth. Players such as Gemini Pharmaceuticals, NUTRIVO, and Ashland comprise in Asia Pacific. The innovative strategies adopted by these players is predicted to boost market development in the region.

The healthcare industry in the United States is mature and advance. It is anticipated to hold a significant share in the market. The increasing prevalence of chronic diseases and expanding food and beverage industry are expected to flourish in market growth. Additionally, the rising acquisitions and collaborations among market players are anticipated to bolster market development. For instance, in August 2021, First Choice ingredients was acquired by Royal DSM. The acquisition is aimed to fulfil the region’s unmet medical requirements. The acquisition is likely to boost economic development and increase scientific research.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Acquisitions and Mergers to Prevail as Key Strategies for Market Players to Maximize their Growth Potential

The nutraceutical contract manufacturing services market is fairly fragmented. The market comprises players that operate at regional and international levels. The market players are trying to penetrate new territories by forming new partnerships and acquiring businesses. They are emphasizing on expanding their distribution channels with agreements through nutraceutical contract manufacturing services.

The rising use of contemporary technologies and the expanding healthcare infrastructure are expected to create new investment pockets for market players. The launch of nutraceutical using advanced production methods is anticipated to boost positions of market players. Strategic alliances are expected to bode well for market players. Furthermore, more product approvals are expected to bode well for market players.

  • Nano9 and Impact BioMedical partnered in January 2021. The partnership is aimed to increase Nano9’s market presence by expanding Impact BioMedical’s direct marketing distribution networks in the United States and Asia Pacific.
  • In September 2021, Lonza launched new HPMC-based VCaps plus capsules. The capsules are aimed to enhance the effectivity of probiotics and other subtle components.
  • AKTA Nutraceuticals launched a new product line in December 2021. The new product line promotes immunity, energy, relaxation, and sleep.
  • In January 2021, a patent was granted in the United States for Gencor’s Testofen fenugreek extract. The patent grant is likely to help the company expand its presence in sports nutrition and men’s health supplements.
  • In June 2021, NutraScience revealed the 56,000 square foot extension of its production facility.

Key Players in the Global Nutraceutical Contract Manufacturing Services Market

  • Ashland
  • Glanbia PLC
  • Biotrex Nutraceuticals
  • Menadiona
  • Martinez Nieto
  • Herbalife International of America, Inc.
  • NUTRASCIENCE LABS
  • Gemini Pharmaceuticals
  • American Health Foundations INC.
  • NUTRIVO
  • Rain Nutrience
  • Biovencer Healthcare Pvt. Ltd.

Nutraceutical Contract Manufacturing Services Market Segmentation

Nutraceutical Contract Manufacturing Services by Product Type:

  • Tablets by Nutraceutical Contract Manufacturing Services
  • Capsules by Nutraceutical Contract Manufacturing Services
  • Liquid Oral by Nutraceutical Contract Manufacturing Services
  • Powder In Sachet/Jar by Nutraceutical Contract Manufacturing Services
  • Gummies by Nutraceutical Contract Manufacturing Services
  • Energy Bars by Nutraceutical Contract Manufacturing Services

Nutraceutical Contract Manufacturing Services by Dosage Form:

  • Dietary Supplements by Nutraceutical Contract Manufacturing Services
  • Functional Food and Beverages by Nutraceutical Contract Manufacturing Services

Nutraceutical Contract Manufacturing Services by Region:

  • Nutraceutical Contract Manufacturing Services in North America Market
  • Nutraceutical Contract Manufacturing Services in Latin America Market
  • Nutraceutical Contract Manufacturing Services in Europe Market
  • Nutraceutical Contract Manufacturing Services in Asia Pacific Market
  • Nutraceutical Contract Manufacturing Services in the Middle East and Africa Market

Frequently Asked Questions

Which Country is Estimated to Drive the Sales of the Digital Wound Measurement Devices in Asia Pacific?

China is expected to drive the regional market with a 4.4% CAGR.

How Big is the Nutraceutical Contract Manufacturing Service Market?

The market is valued at US$ 149.41 billion in 2023.

What is the Adoption Rate of the Nutraceutical Contract Manufacturing Services?

The global adoption of such services was progressed at 12.05% in 2022.

Who are the Leaders in Providing Nutraceutical Contract Manufacturing Services?

Ashland, Glanbia, and Biotrex are the top service providers in current years.

What is the Contribution of Asia Pacific in the Nutraceutical Contract Manufacturing Service Market?

The region accounted for more than 40% of the global market share in 2022.

Table of Content

1. Executive Summary | Nutraceutical Contract Manufacturing Services Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dosage Form

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Dosage Form, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Dosage Form, 2023 to 2033

        5.3.1. Tablets

        5.3.2. Capsules

        5.3.3. Liquid Oral

        5.3.4. Gummies

        5.3.5. Energy Bars

        5.3.6. Other suitable forms

    5.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Dosage Form, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        6.3.1. Dietary Supplements

            6.3.1.1. Proteins & Amino Acids Supplement

            6.3.1.2. Weight Management and Meal Replacer Supplement

            6.3.1.3. Multivitamin, Multi-Mineral, and Antioxidant Supplement

            6.3.1.4. Other Supplements

        6.3.2. Functional Food and Beverages

    6.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. South Asia

        7.3.5. East Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Dosage Form

        8.2.3. By Product

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Dosage Form

        8.3.3. By Product

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Dosage Form

        9.2.3. By Product

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Dosage Form

        9.3.3. By Product

    9.4. Key Takeaways

10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Dosage Form

        10.2.3. By Product

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Dosage Form

        10.3.3. By Product

    10.4. Key Takeaways

11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Malaysia

            11.2.1.3. Singapore

            11.2.1.4. Thailand

            11.2.1.5. Rest of South Asia

        11.2.2. By Dosage Form

        11.2.3. By Product

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Dosage Form

        11.3.3. By Product

    11.4. Key Takeaways

12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Dosage Form

        12.2.3. By Product

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Dosage Form

        12.3.3. By Product

    12.4. Key Takeaways

13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Dosage Form

        13.2.3. By Product

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Dosage Form

        13.3.3. By Product

    13.4. Key Takeaways

14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Dosage Form

        14.2.3. By Product

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Dosage Form

        14.3.3. By Product

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Dosage Form

            15.1.2.2. By Product

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Dosage Form

            15.2.2.2. By Product

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Dosage Form

            15.3.2.2. By Product

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Dosage Form

            15.4.2.2. By Product

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Dosage Form

            15.5.2.2. By Product

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Dosage Form

            15.6.2.2. By Product

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Dosage Form

            15.7.2.2. By Product

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Dosage Form

            15.8.2.2. By Product

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Dosage Form

            15.9.2.2. By Product

    15.10. India

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Dosage Form

            15.10.2.2. By Product

    15.11. Malaysia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Dosage Form

            15.11.2.2. By Product

    15.12. Singapore

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Dosage Form

            15.12.2.2. By Product

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Dosage Form

            15.13.2.2. By Product

    15.14. China

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Dosage Form

            15.14.2.2. By Product

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Dosage Form

            15.15.2.2. By Product

    15.16. South Korea

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Dosage Form

            15.16.2.2. By Product

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Dosage Form

            15.17.2.2. By Product

    15.18. New Zealand

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Dosage Form

            15.18.2.2. By Product

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Dosage Form

            15.19.2.2. By Product

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Dosage Form

            15.20.2.2. By Product

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Dosage Form

            15.21.2.2. By Product

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Dosage Form

        16.3.3. By Product

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Ashland

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Glanbia plc

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Herbalife International of America, Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Biotrex Nutraceuticals

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Martínez Nieto

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Menadiona

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. NUTRASCIENCE LABS

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. NUTRIVO

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. American Health Foundations, INC.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Gemini Pharmaceutical

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Biovencer Healthcare Pvt Ltd

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. Rain Nutrience

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: Latin America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 11: Europe Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 12: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: South Asia Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 15: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 17: East Asia Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 18: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: Oceania Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 21: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 22: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 23: MEA Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033

Table 24: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Product, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 7: Global Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 10: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 13: Global Market Attractiveness by Dosage Form, 2023 to 2033

Figure 14: Global Market Attractiveness by Product, 2023 to 2033

Figure 15: Global Market Attractiveness by Region, 2023 to 2033

Figure 16: North America Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 17: North America Market Value (US$ Million) by Product, 2023 to 2033

Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 22: North America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 28: North America Market Attractiveness by Dosage Form, 2023 to 2033

Figure 29: North America Market Attractiveness by Product, 2023 to 2033

Figure 30: North America Market Attractiveness by Country, 2023 to 2033

Figure 31: Latin America Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 32: Latin America Market Value (US$ Million) by Product, 2023 to 2033

Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 37: Latin America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 40: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 43: Latin America Market Attractiveness by Dosage Form, 2023 to 2033

Figure 44: Latin America Market Attractiveness by Product, 2023 to 2033

Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 46: Europe Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 47: Europe Market Value (US$ Million) by Product, 2023 to 2033

Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 52: Europe Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 53: Europe Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 55: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 56: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 58: Europe Market Attractiveness by Dosage Form, 2023 to 2033

Figure 59: Europe Market Attractiveness by Product, 2023 to 2033

Figure 60: Europe Market Attractiveness by Country, 2023 to 2033

Figure 61: South Asia Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 62: South Asia Market Value (US$ Million) by Product, 2023 to 2033

Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 67: South Asia Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 68: South Asia Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 70: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 71: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 72: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 73: South Asia Market Attractiveness by Dosage Form, 2023 to 2033

Figure 74: South Asia Market Attractiveness by Product, 2023 to 2033

Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 76: East Asia Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 77: East Asia Market Value (US$ Million) by Product, 2023 to 2033

Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 82: East Asia Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 83: East Asia Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 85: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 86: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 88: East Asia Market Attractiveness by Dosage Form, 2023 to 2033

Figure 89: East Asia Market Attractiveness by Product, 2023 to 2033

Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 91: Oceania Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 92: Oceania Market Value (US$ Million) by Product, 2023 to 2033

Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 97: Oceania Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 98: Oceania Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 100: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 101: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 102: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 103: Oceania Market Attractiveness by Dosage Form, 2023 to 2033

Figure 104: Oceania Market Attractiveness by Product, 2023 to 2033

Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 106: MEA Market Value (US$ Million) by Dosage Form, 2023 to 2033

Figure 107: MEA Market Value (US$ Million) by Product, 2023 to 2033

Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 112: MEA Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033

Figure 113: MEA Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033

Figure 114: MEA Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033

Figure 115: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 116: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 117: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 118: MEA Market Attractiveness by Dosage Form, 2023 to 2033

Figure 119: MEA Market Attractiveness by Product, 2023 to 2033

Figure 120: MEA Market Attractiveness by Country, 2023 to 2033

Recommendations

Food and Beverage

Nutraceuticals Market

Published : September 2023

Food and Beverage

Nutraceutical Excipients Market

Published : February 2023

Explore Healthcare Insights

View Reports

Nutraceutical Contract Manufacturing Services Market